Finance

Lists
Why is GERN down ४.६३%?
Dive Deeper
GERN:NASDAQ
Geron Corp
US$ ०.८७
-४.६३%
(-०.०४२) 1D
US$ ०.८९
+२.४५% (+०.०२१)
After hours
Closed: नोभेम्बर २०, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GERN...
Open
US$ ०.८९
High
US$ ०.९२
Low
US$ ०.८६
Mkt. cap
५६.२८ करोड
Avg. vol.
१.५९ करोड
Volume
१.३८ करोड
52-wk high
US$ २.०१
52-wk low
US$ ०.८४
EPS
-US$ ०.०७
Beta
०.६२
Shares outstanding
६४.४२ करोड
No. of employees
२५८
Open
US$ ०.८९
High
US$ ०.९२
Low
US$ ०.८६
Mkt. cap
५६.२८ करोड
Avg. vol.
१.५९ करोड
Volume
१.३८ करोड
52-wk high
US$ २.०१
52-wk low
US$ ०.८४
EPS
-US$ ०.०७
Beta
०.६२
Shares outstanding
६४.४२ करोड
No. of employees
२५८
News stories
From web sources and news partners
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees२५८
Founded१९९०
HeadquartersMenlo Park, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitegeron.com
Analyst ratings
Based on 4 analysts giving stock ratings to GERN in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for GERN in the last 3 months.
Highest
Current US$ ०.८७
US$ ५.०० (+४७४.२५%)
Average
US$ ३.८३ (+३३९.८८%)
Lowest
US$ ३.०० (+२४४.५५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
US$ ५.००
+४७४.३%
11/05/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
US$ ३.५०
+३०२%
11/05/2026
Tara Bancroft
TD Cowen
Buy
Maintained
US$ ३.००
+२४४.६%
11/04/2026
Emily Bodnar
H.C. Wainwright
Hold
Maintained
-
-
09/21/2026
Unknown Analyst
Wedbush
Buy
Reiterated
US$ ६.००
+५८९.१%
08/06/2026
Gil Blum
Needham
Buy
Maintained
US$ ४.००
+३५९.४%
08/05/2026
Corinne Johnson
Goldman Sachs
Sell
Reiterated
US$ १.००
+१४.९%
02/25/2026
Last report
२०२६ नोभेम्बर ४
Fiscal period
Q3 2026
US$ ०.०० / -US$ ०.०१
+११९.००%beat
Revenue / Est. (USD)
६.०२ करोड / ६.०४ करोड
-०.२८%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
४.८० करोड
५.१८ करोड
५.७५ करोड
६.०२ करोड
Cost of goods sold
१.४९ करोड
१.६६ करोड
३.१३ करोड
१.८८ करोड
Cost of revenue
१.४९ करोड
१.६६ करोड
३.१३ करोड
१.८८ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.१७ करोड
३.५४ करोड
३.८९ करोड
३.५७ करोड
Operating expense
४.१७ करोड
३.५४ करोड
३.८९ करोड
३.५७ करोड
Total operating expenses
५.६५ करोड
५.२१ करोड
७.०१ करोड
५.४५ करोड
Operating income
-८५.०८ लाख
-२.३६ लाख
-१.२७ करोड
५७.२८ लाख
Other non operating income
-७०.०० हजार
-७४.०० हजार
-९.०० हजार
-१९.०० हजार
EBT including unusual items
-२.८९ करोड
-३६.४२ लाख
-१.६७ करोड
१३.५० लाख
EBT excluding unusual items
-१.१८ करोड
-४०.३६ लाख
-१.६८ करोड
१५.४४ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.८९ करोड
-३६.४२ लाख
-१.६७ करोड
१३.५० लाख
Net profit margin
-६०.११%
-७.०३%
-२९.०२%
२.२४%
Earnings per share
-०.०२
-०.००
-०.०२
०.००
Interest and investment income
४०.४५ लाख
३४.२१ लाख
२९.७१ लाख
३०.२५ लाख
Interest expense
-७२.९७ लाख
-७१.४७ लाख
-७१.४६ लाख
-७२.०७ लाख
Net interest expenses
-३२.५२ लाख
-३७.२६ लाख
-४१.७५ लाख
-४१.८२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-८४.२१ लाख
-१.०२ लाख
-१.२५ करोड
५८.६५ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू